D-1670-2019 Class II Terminated
FDA drug recall D-1670-2019 was initiated by RXQ Compounding LLC on June 19, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated September 16, 2022). Affected quantity: N/A.
Recall Details
- Product Type
- Drugs
- Report Date
- August 14, 2019
- Initiation Date
- June 19, 2019
- Termination Date
- September 16, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- N/A
Product Description
KETAMINE 10 MG/ML INJ SOL SYR (C-III), [a) 2 ML NDC: 70731-0132-02; b) 5 ML NDC: 70731-0132-05] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Nationwide USA
Code Information
All lots within expiry